Interestingly, we found that Gli1 was significantly up‐regulated in breast cancer tissues, whereas PTCH1, SMO, Gli1 and HHIP at mRNA and protein levels were all down‐regulated after controlling for EGOT overexpression (Fig. 3). This evidence concerns the gene GLI1 and breast cancer.